What is the current annual cash & cash equivalents of CVS?

As of today, CVS annual cash & cash equivalents is $10.66B

What is 1-year change in CVS annual cash & cash equivalents?

CVS annual cash & cash equivalents is down -3.89% year-over-year

What is 3-year change in CVS annual cash & cash equivalents?

CVS annual cash & cash equivalents is down -32.84% over the past 3 years

How far is CVS annual cash & cash equivalents from its all-time high?

CVS annual cash & cash equivalents is currently -32.84% below its historical high of $15.87B set on December 31, 2022

How does CVS annual cash & cash equivalents rank versus sector peers?

CVS annual cash & cash equivalents is higher than 99.29% of companies in Healthcare sector

When is CVS next annual earnings release?

The next annual earnings release for CVS is on February 9, 2027

What is the current quarterly cash & cash equivalents of CVS?

As of today, CVS quarterly cash & cash equivalents is $14.89B

What is CVS quarterly cash & cash equivalents most recent change?

CVS quarterly cash & cash equivalents was up +6.66% on September 30, 2026

What is 1-year change in CVS quarterly cash & cash equivalents?

CVS quarterly cash & cash equivalents is up +31.87% year-over-year

How far is CVS quarterly cash & cash equivalents from its all-time high?

CVS quarterly cash & cash equivalents is currently -66.11% below its historical high of $43.93B set on June 30, 2018

How does CVS quarterly cash & cash equivalents rank versus sector peers?

CVS quarterly cash & cash equivalents is higher than 99.64% of companies in Healthcare sector

When is CVS next earnings release?

The next earnings release for CVS is on February 9, 2027

CVS Cash & Equivalents History & Chart Since 1980

Annual Cash & Cash Equivalents

$10.66B$431.00M-3.89%

December 31, 2025

Summary

Current Value: As of today, CVS annual cash & cash equivalents is $10.66B, down -3.89% on December 31, 2025
Historical Performance: CVS annual cash & cash equivalents is down -32.84% over the past 3 years, down -1.81% over the past 5 years
All-Time High Comparison: CVS annual cash & cash equivalents is currently -32.84% below its historical high of $15.87B set on December 31, 2022
3-Year Low Comparison: CVS annual cash & cash equivalents is at its 3-year low
Sector Comparison: CVS annual cash & cash equivalents is higher than 99.29% of companies in Healthcare sector

Cash and Cash Equivalents Chart

beforeafter

SUGGESTED SERIES

Performance

CVS Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual Cash & Cash Equivalents	Dec 31, 25	$10.66B	-3.9%	-32.8%	-1.8%	+644.7%
Quarterly Cash & Cash Equivalents	Sep 30, 26	$14.89B	+31.9%	-8.6%	+15.9%	+769.6%
Price	Nov 6, 26	$83.85	+6.6%	+18.0%	-10.6%	+120.5%
Annual Current Assets	Dec 31, 25	$74.71B	+8.8%	+13.8%	+32.5%	+322.0%
Annual Total Liabilities	Dec 31, 25	$185.68B	+0.3%	+13.0%	+10.0%	+659.9%
Annual Working Capital	Dec 31, 25	-$13.98B	+12.4%	-269.0%	-147.5%	-310.6%
Annual Net Income	Dec 31, 25	$1.73B	-62.3%	-60.1%	-76.0%	-49.8%

Cash and Cash Equivalents Highs

CVS Annual Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
3Y	$15.87B	N/A	-32.8%
5Y	$15.87B	Dec 31, 22	-32.8%
All	$15.87B	Dec 31, 22	-32.8%

Cash and Cash Equivalents Lows

CVS Annual Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
3Y	$10.66B	Dec 31, 25	at low
5Y	$10.66B	Dec 31, 25	at low
All	$78.67M	Dec 31, 91	>+9999.0%

Cash and Cash Equivalents History

Year	Value	Change
2025	$10.66B	-3.9%
2024	$11.09B	-4.0%
2023	$11.55B	-27.2%
2022	$15.87B	+1.8%
2021	$15.59B	+43.6%
2020	$10.85B	+34.7%
2019	$8.06B	+22.3%
2018	$6.59B	+261.7%
2017	$1.82B	-47.3%
2016	$3.46B	+35.8%
2015	$2.55B	+1.3%
2014	$2.52B	-39.8%
2013	$4.18B	+202.7%
2012	$1.38B	-2.7%
2011	$1.42B	-0.9%
2010	$1.43B	+31.2%
2009	$1.09B	-19.3%
2008	$1.35B	+24.7%
2007	$1.08B	+104.3%
2006	$530.70M	+3.4%
2005	$513.40M	+30.9%
2004	$392.30M	-53.5%
2003	$843.20M	+20.4%

Year	Value	Change
2002	$700.40M	+196.4%
2001	$236.30M	-29.9%
2000	$337.30M	+46.7%
1999	$230.00M	+27.2%
1998	$180.80M	+7.3%
1997	$168.50M	-72.1%
1996	$603.30M	+98.1%
1995	$304.58M	+160.2%
1994	$117.04M	+44.5%
1993	$80.97M	-44.2%
1992	$145.14M	+84.5%
1991	$78.67M	-29.2%
1990	$111.09M	-69.9%
1989	$368.81M	+23.6%
1988	$298.35M	-12.7%
1987	$341.82M	+4.6%
1986	$326.78M	+7.3%
1985	$304.67M	+62.2%
1984	$187.82M	+2.8%
1983	$182.78M	+49.4%
1982	$122.37M	-22.1%
1981	$157.02M	-9.6%
1980	$173.65M	-

FAQ

What is the current annual cash & cash equivalents of CVS?: As of today, CVS annual cash & cash equivalents is $10.66B
What is 1-year change in CVS annual cash & cash equivalents?: CVS annual cash & cash equivalents is down -3.89% year-over-year
What is 3-year change in CVS annual cash & cash equivalents?: CVS annual cash & cash equivalents is down -32.84% over the past 3 years
How far is CVS annual cash & cash equivalents from its all-time high?: CVS annual cash & cash equivalents is currently -32.84% below its historical high of $15.87B set on December 31, 2022
How does CVS annual cash & cash equivalents rank versus sector peers?: CVS annual cash & cash equivalents is higher than 99.29% of companies in Healthcare sector
When is CVS next annual earnings release?: The next annual earnings release for CVS is on February 9, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Quarterly Cash & Cash Equivalents

$14.89B$929.00M+6.66%

September 30, 2026

Summary

Current Value: As of today, CVS quarterly cash & cash equivalents is $14.89B, up +6.66% on September 30, 2026
Historical Performance: CVS quarterly cash & cash equivalents is up +31.87% year-over-year, down -8.58% over the past 3 years
All-Time High Comparison: CVS quarterly cash & cash equivalents is currently -66.11% below its historical high of $43.93B set on June 30, 2018
3-Year Low Comparison: CVS quarterly cash & cash equivalents is +52.77% above its 3-year low of $9.75B reached on September 30, 2024
Sector Comparison: CVS quarterly cash & cash equivalents is higher than 99.64% of companies in Healthcare sector

Performance

CVS Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly Cash & Cash Equivalents	Sep 30, 26	$14.89B	+6.7%	+31.9%	-8.6%	+15.9%
Annual Cash & Cash Equivalents	Dec 31, 25	$10.66B	–	-3.9%	-32.8%	-1.8%
Price	Nov 6, 26	$83.85	-12.9%	+6.6%	+18.0%	-10.6%
Quarterly Current Assets	Sep 30, 26	$79.39B	+5.4%	+3.0%	+13.2%	+30.5%
Quarterly Total Liabilities	Sep 30, 26	$177.39B	+2.0%	-2.6%	+0.3%	+10.7%
Quarterly Working Capital	Sep 30, 26	-$13.71B	-17.2%	+12.1%	-20.1%	-254.4%
Quarterly Net Income	Sep 30, 26	$2.17B	-27.5%	+154.4%	-4.2%	+36.8%

Quarterly Cash & Cash Equivalents Highs

CVS Quarterly Cash & Cash Equivalents Highs Comparison
Period	High	Date	Current
1Y	$14.89B	Sep 30, 26	at high
3Y	$16.32B	Jun 30, 24	-8.8%
5Y	$20.14B	Sep 30, 22	-26.1%
All	$43.93B	Jun 30, 18	-66.1%

Quarterly Cash & Cash Equivalents Lows

CVS Quarterly Cash & Cash Equivalents Lows Comparison
Period	Low	Date	Current
1Y	$10.66B	Dec 31, 25	+39.7%
3Y	$9.75B	Sep 30, 24	+52.8%
5Y	$9.75B	Sep 30, 24	+52.8%
All	$62.00M	Jun 27, 98	>+9999.0%

Quarterly Cash & Cash Equivalents History

Month	Value	Change
Sep 2026	$14.89B	+6.7%
Jun 2026	$13.96B	+18.1%
Mar 2026	$11.82B	+10.9%
Dec 2025	$10.66B	-5.6%
Sep 2025	$11.29B	-20.6%
Jun 2025	$14.22B	+11.8%
Mar 2025	$12.72B	+14.7%
Dec 2024	$11.09B	+13.8%
Sep 2024	$9.75B	-40.3%
Jun 2024	$16.32B	+24.2%
Mar 2024	$13.14B	+13.8%
Dec 2023	$11.55B	-29.1%
Sep 2023	$16.28B	-4.1%
Jun 2023	$16.97B	-4.8%
Mar 2023	$17.83B	+12.4%
Dec 2022	$15.87B	-21.2%
Sep 2022	$20.14B	+33.2%
Jun 2022	$15.12B	+6.1%
Mar 2022	$14.26B	-8.6%
Dec 2021	$15.59B	+21.4%
Sep 2021	$12.84B	+26.8%
Jun 2021	$10.13B	+15.2%
Mar 2021	$8.79B	-19.0%
Dec 2020	$10.85B	-10.2%
Sep 2020	$12.09B	-30.8%
Jun 2020	$17.47B	+37.4%
Mar 2020	$12.71B	+57.8%
Dec 2019	$8.06B	+6.9%
Sep 2019	$7.53B	-11.7%
Jun 2019	$8.53B	+2.4%
Mar 2019	$8.33B	+26.4%
Dec 2018	$6.59B	-84.2%
Sep 2018	$41.70B	-5.1%
Jun 2018	$43.93B	+4.2%
Mar 2018	$42.16B	+2,215.0%
Dec 2017	$1.82B	-28.9%
Sep 2017	$2.56B	+18.0%
Jun 2017	$2.17B	-5.8%
Mar 2017	$2.30B	-33.4%
Dec 2016	$3.46B	+52.8%
Sep 2016	$2.26B	+87.5%
Jun 2016	$1.21B	-35.2%
Mar 2016	$1.86B	-26.8%
Dec 2015	$2.55B	-15.4%
Sep 2015	$3.01B	+114.5%
Jun 2015	$1.40B	-14.1%
Mar 2015	$1.63B	-35.0%
Dec 2014	$2.52B	+107.9%
Sep 2014	$1.21B	-29.3%
Jun 2014	$1.71B	-39.9%
Mar 2014	$2.85B	-31.8%
Dec 2013	$4.18B	+159.0%
Sep 2013	$1.61B	+36.8%
Jun 2013	$1.18B	-24.2%
Mar 2013	$1.56B	+12.8%
Dec 2012	$1.38B	+11.5%
Sep 2012	$1.24B	-32.3%
Jun 2012	$1.83B	-17.5%
Mar 2012	$2.22B	+56.3%
Dec 2011	$1.42B	-17.2%
Sep 2011	$1.71B	-23.3%
Jun 2011	$2.23B	+3.0%
Mar 2011	$2.17B	+51.5%
Dec 2010	$1.43B	+45.6%
Sep 2010	$983.00M	-11.5%
Jun 2010	$1.11B	+5.7%
Mar 2010	$1.05B	-3.7%
Dec 2009	$1.09B	-3.9%
Sep 2009	$1.14B	-7.3%
Jun 2009	$1.23B	+22.8%
Mar 2009	$997.40M	-26.2%
Dec 2008	$1.35B	+5.5%
Sep 2008	$1.28B	+108.3%
Jun 2008	$615.70M	-24.7%
Mar 2008	$818.20M	-24.5%

Month	Value	Change
Dec 2007	$1.08B	+43.7%
Sep 2007	$754.60M	-19.4%
Jun 2007	$935.80M	+26.8%
Mar 2007	$738.20M	+39.1%
Dec 2006	$530.70M	+34.5%
Sep 2006	$394.60M	-25.9%
Jun 2006	$532.30M	+37.5%
Mar 2006	$387.10M	-24.6%
Dec 2005	$513.40M	+39.4%
Sep 2005	$368.20M	-11.1%
Jun 2005	$414.10M	+27.9%
Mar 2005	$323.80M	-8.6%
Sep 2004	$354.40M	-43.1%
Jun 2004	$622.90M	-4.4%
Mar 2004	$651.50M	-10.4%
Sep 2003	$727.30M	+28.3%
Jun 2003	$566.80M	-12.5%
Mar 2003	$648.10M	+198.3%
Sep 2002	$217.30M	-34.8%
Jun 2002	$333.30M	-26.5%
Mar 2002	$453.50M	+11.5%
Sep 2001	$406.60M	+48.5%
Jun 2001	$273.80M	-8.7%
Mar 2001	$299.80M	+39.5%
Sep 2000	$214.90M	+17.8%
Jun 2000	$182.50M	-22.9%
Mar 2000	$236.60M	+39.3%
Sep 1999	$169.90M	-26.9%
Jun 1999	$232.30M	+69.8%
Mar 1999	$136.80M	+9.1%
Sep 1998	$125.40M	+102.3%
Jun 1998	$62.00M	-44.7%
Mar 1998	$112.20M	-41.7%
Dec 1997	$192.50M	+26.7%
Sep 1997	$151.90M	+102.8%
Jun 1997	$74.90M	-77.6%
Mar 1997	$334.60M	-29.1%
Dec 1996	$471.80M	+427.2%
Sep 1996	$89.50M	+8.7%
Jun 1996	$82.30M	-8.6%
Mar 1996	$90.00M	-30.6%
Dec 1995	$129.60M	+61.8%
Sep 1995	$80.10M	-3.1%
Jun 1995	$82.70M	-6.3%
Mar 1995	$88.30M	-24.5%
Dec 1994	$117.00M	+41.1%
Sep 1994	$82.90M	+16.9%
Jun 1994	$70.90M	-37.4%
Mar 1994	$113.20M	+39.8%
Dec 1993	$81.00M	-11.7%
Sep 1993	$91.70M	+22.8%
Jun 1993	$74.70M	-13.0%
Mar 1993	$85.90M	-40.8%
Dec 1992	$145.10M	+41.8%
Sep 1992	$102.30M	-9.0%
Jun 1992	$112.40M	-19.3%
Mar 1992	$139.20M	+76.9%
Dec 1991	$78.70M	+1.7%
Sep 1991	$77.40M	-49.9%
Jun 1991	$154.50M	+14.3%
Mar 1991	$135.20M	+21.7%
Dec 1990	$111.10M	+11.1%
Sep 1990	$100.00M	+0.8%
Jun 1990	$99.20M	+31.9%
Mar 1990	$75.20M	-79.6%
Dec 1989	$368.80M	+371.0%
Sep 1989	$78.30M	-68.5%
Jun 1989	$248.60M	+273.8%
Mar 1989	$66.50M	-77.7%
Dec 1988	$298.40M	-12.7%
Dec 1987	$341.80M	+4.6%
Dec 1986	$326.80M	+7.3%
Dec 1985	$304.70M	+62.2%
Dec 1984	$187.80M	-

FAQ

What is the current quarterly cash & cash equivalents of CVS?: As of today, CVS quarterly cash & cash equivalents is $14.89B
What is CVS quarterly cash & cash equivalents most recent change?: CVS quarterly cash & cash equivalents was up +6.66% on September 30, 2026
What is 1-year change in CVS quarterly cash & cash equivalents?: CVS quarterly cash & cash equivalents is up +31.87% year-over-year
How far is CVS quarterly cash & cash equivalents from its all-time high?: CVS quarterly cash & cash equivalents is currently -66.11% below its historical high of $43.93B set on June 30, 2018
How does CVS quarterly cash & cash equivalents rank versus sector peers?: CVS quarterly cash & cash equivalents is higher than 99.64% of companies in Healthcare sector
When is CVS next earnings release?: The next earnings release for CVS is on February 9, 2027

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

CVS Official Website www.cvshealth.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm
CVS Profile on Yahoo Finance finance.yahoo.com/quote/CVS
CVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cvs